Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This appears to be a metadata update with no impact on study details or content.
    Difference
    0.0%
    Check dated 2026-01-14T03:24:20.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Locations section updated to add a consolidated list of study sites across California, Colorado, District of Columbia, Florida, Georgia, Indiana, Louisiana, Maryland, Missouri, New York, North Carolina, Tennessee, Virginia, and Wisconsin. A new Revision: v3.3.3 appears and older state-specific locations and the HHS Vulnerability Disclosure link were removed (Revision: v3.3.2).
    Difference
    1%
    Check dated 2025-12-23T21:40:35.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a notice that publications are automatically filled from PubMed and that the revision is v3.3.2. Removed the previous notice describing PubMed-sourced publications and the older revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:10.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removed the banner about government funding status and NIH operating updates; this does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:52:42.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No significant changes detected; the page content remains the same, with only minor visual differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:37:10.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Page updated to v3.2.0 with a new government-operating status notice; previous version v3.1.0 reference removed. Core content remains, but timing/operational details are updated.
    Difference
    3%
    Check dated 2025-10-06T04:53:43.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.